CASE
HOMEPAGE

2002 HRSA RWC CONFERENCE

CASE STUDY ABSTRACT, OBJECTIVES & DESIGN

CASE STUDY AMENDMENT: IMPACT OF 9/11 ON PWH/As TAKING HAART

CASE STAFF & GRANTEE ROSTER

DATA COLLECTION TOOLS

CASE STUDY DATA ANALYSIS PLAN

DISSEMINATION ACTIVITIES

RESOURCES & LINKS

CASE
The Center for Adherence Support Evaluation
at the New York Academy of Medicine

The CASE mission is to increase understanding of how best to support HIV treatment adherence. In order to gain this understanding, the CASE project uses several types of data collection tools. They are as follow.

Cross-site client-level data collection tools
These consist of baseline, follow-up interviews and encounter forms. They are designed to assess client-level changes in knowledge, attitudes, and co-behaviors believed to be associated with consistency of adherence to a HAART regimen in relationship to adherence support services received by that client.

Qualitative/site assessment data collection tools
These tools consist of 2 site assessments (one to be completed by the site, one to be completed by CASE staff), a client interview, a provider interview, and a clinical provider interview. A qualitative site or system-level assessment of each grantee's program should enrich our understanding of how persons on HAART characterize their participation in adherence support programs and their experience with HIV medication-taking. In addition, it should provide information about the context in which the interventions are delivered, clients' perspectives of the program, and the ways in which organizational and provider factors influence the consistency of clients' HIV medication adherence. With these tools, we hope to be able to capture program ingredients and organizational characteristics that contribute to the effectiveness or ineffectiveness of adherence support interventions.

Our goal is to use the data gathered with our cross-site client level data collection tools and qualitative/site assessment data collection tools in order to shape the design of replicable interventions that can be tested with other populations on HAART regimens or contemplating initiation of HAART.